The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc announced the launch of Versus, an evolution of its Verse cannabis value brand, as well as a new ultra-premium cannabis brand, Contraband.
The company said this repositioning and expansion mark the beginning of a strategic, multi-step plan to grow the Valens brand portfolio into one of the top performers in the adult recreational market.
“Winning in the value price point across multiple categories will give us a solid foundation,” Valens CEO Tyler Robson said in a statement.
READ: The Valens Company CEO says company 'well-positioned to drive revenue growth in 2022'
“From there, Contraband is part of our strategy to build an ultra-premium brand offering, and ultimately create one of the most comprehensive and effective portfolios in the marketplace,” Robson added.
Valens noted the Versus launch follows its acquisition of Verse Cannabis in September 2021, which, with its acquisition of Citizen Stash, propelled the company into a top-tier market share position in Canada, while remaining a partner-of-choice for third-party custom manufacturing partners.
It added that the Versus launch involves the introduction of two net new product lines this week, plus a rebranding of the full Verse portfolio this spring, for a total of about 20 stock-keeping units (SKUs) across product categories.
Contraband, meanwhile, will be launched this week with two sizes of CNDYLND flower, 3.5 grams and 14 grams, beginning in Ontario, followed later this year by pre-rolls, concentrates, and vapes.
Consumers interested in finding out more about Versus and its line of products can go here, while more information about Contraband can be found here.
The Valens Company (TSX:VLNS, OTCQX:VLNCF) is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. It provides proprietary cannabis processing services, in addition to product development, manufacturing, and commercialization of cannabis consumer-packaged goods.
The company's products are formulated for the medical, health and wellness, and recreational consumer segments, and are offered across all cannabis product categories with a focus on quality and innovation.
Contact Sean at sean@proactiveinvestors.com